RHOAY42C-driven cell lineage plasticity and immune remodeling of diffuse gastric cancer [CUT&Run]

RHOAY42C is a recurrent mutation in DGA, yet its independent oncogenic role remains unclear. We used genetically engineered gastric organoid models to demonstrate that RHOAY42C, along with KrasG12D activation and Trp53 loss (RKP), is sufficient to drive DGA without loss of E-cadherin.

Integrated single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (Xenium In Situ) revealed that RKP tumors exhibit mucinous histopathology and a unique lineage trajectory originating from Aqp5+ cells and differentiating into Muc1/Muc4+ cells via YAP1 signaling. RKP tumors establish a highly immunosuppressive tumor microenvironment in which AREG-mediated activation of EGFR promotes T cell exhaustion. Unlike E-cadherin loss-induced DGA, RKP tumors display strong susceptibility to PD-1 blockade.